Iambic Therapeutics

2 articles

Nvidia-backed Iambic Therapeutics Launches IPO as Biotechs Buck Market Gloom

Nvidia-backed Iambic Therapeutics launches an IPO targeting $159.4 million funding, valuing the AI-driven drugmaker at up to $805.8 million amid cautious market conditions.

reuters · 2026-10-08 05:08

Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on

Iambic Therapeutics, backed by Nvidia and Qatar Investment Authority, filed for a US IPO amidst a resilient biotech market. The company leverages an AI platform to develop small molecule therapies for

reuters · 2026-09-21 14:41